These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 12746497)

  • 1. Asialoerythropoietin is a nonerythropoietic cytokine with broad neuroprotective activity in vivo.
    Erbayraktar S; Grasso G; Sfacteria A; Xie QW; Coleman T; Kreilgaard M; Torup L; Sager T; Erbayraktar Z; Gokmen N; Yilmaz O; Ghezzi P; Villa P; Fratelli M; Casagrande S; Leist M; Helboe L; Gerwein J; Christensen S; Geist MA; Pedersen LØ; Cerami-Hand C; Wuerth JP; Cerami A; Brines M
    Proc Natl Acad Sci U S A; 2003 May; 100(11):6741-6. PubMed ID: 12746497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Asialoerythropoietin attenuates neuronal cell death in the hippocampal CA1 region after transient forebrain ischemia in a gerbil model.
    Yamashita T; Nonoguchi N; Ikemoto T; Miyatake S; Kuroiwa T
    Neurol Res; 2010 Nov; 32(9):957-62. PubMed ID: 20444326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amelioration of spinal cord compressive injury by pharmacological preconditioning with erythropoietin and a nonerythropoietic erythropoietin derivative.
    Grasso G; Sfacteria A; Erbayraktar S; Passalacqua M; Meli F; Gokmen N; Yilmaz O; La Torre D; Buemi M; Iacopino DG; Coleman T; Cerami A; Brines M; Tomasello F
    J Neurosurg Spine; 2006 Apr; 4(4):310-8. PubMed ID: 16619678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroprotective effects of erythropoietin pretreatment in a rodent model of transient middle cerebral artery occlusion.
    Ratilal BO; Arroja MM; Rocha JP; Fernandes AM; Barateiro AP; Brites DM; Pinto RM; Sepodes BM; Mota-Filipe HD
    J Neurosurg; 2014 Jul; 121(1):55-62. PubMed ID: 24702327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The erythropoietin-derived peptide MK-X and erythropoietin have neuroprotective effects against ischemic brain damage.
    Yoo SJ; Cho B; Lee D; Son G; Lee YB; Soo Han H; Kim E; Moon C; Moon C
    Cell Death Dis; 2017 Aug; 8(8):e3003. PubMed ID: 28817120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Post-ischemic treatment with erythropoietin or carbamylated erythropoietin reduces infarction and improves neurological outcome in a rat model of focal cerebral ischemia.
    Wang Y; Zhang ZG; Rhodes K; Renzi M; Zhang RL; Kapke A; Lu M; Pool C; Heavner G; Chopp M
    Br J Pharmacol; 2007 Aug; 151(8):1377-84. PubMed ID: 17603558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The nonerythropoietic asialoerythropoietin protects against neonatal hypoxia-ischemia as potently as erythropoietin.
    Wang X; Zhu C; Wang X; Gerwien JG; Schrattenholz A; Sandberg M; Leist M; Blomgren K
    J Neurochem; 2004 Nov; 91(4):900-10. PubMed ID: 15525344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutant erythropoietin without erythropoietic activity is neuroprotective against ischemic brain injury.
    Gan Y; Xing J; Jing Z; Stetler RA; Zhang F; Luo Y; Ji X; Gao Y; Cao G
    Stroke; 2012 Nov; 43(11):3071-7. PubMed ID: 22984011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A neuroprotective derivative of erythropoietin that is not erythropoietic.
    Doggrell SA
    Expert Opin Investig Drugs; 2004 Nov; 13(11):1517-9. PubMed ID: 15500399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of erythropoietin and its derivatives to treat spinal cord injury.
    Mofidi A; Bader A; Pavlica S
    Mini Rev Med Chem; 2011 Aug; 11(9):763-70. PubMed ID: 21707531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intranasal recombinant human erythropoietin protects rats against focal cerebral ischemia.
    Yu YP; Xu QQ; Zhang Q; Zhang WP; Zhang LH; Wei EQ
    Neurosci Lett; 2005 Oct; 387(1):5-10. PubMed ID: 16054296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitory effect on cerebral inflammatory agents that accompany traumatic brain injury in a rat model: a potential neuroprotective mechanism of recombinant human erythropoietin (rhEPO).
    Chen G; Shi JX; Hang CH; Xie W; Liu J; Liu X
    Neurosci Lett; 2007 Oct; 425(3):177-82. PubMed ID: 17825990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Erythropoietin-mediated protection of insect brain neurons involves JAK and STAT but not PI3K transduction pathways.
    Miljus N; Heibeck S; Jarrar M; Micke M; Ostrowski D; Ehrenreich H; Heinrich R
    Neuroscience; 2014 Jan; 258():218-27. PubMed ID: 24269933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolation and characterization of a subset of erythropoietin glycoforms with cytoprotective but minimal erythropoietic activity.
    Mattio M; Ceaglio N; Oggero M; Perotti N; Amadeo I; Orozco G; Forno G; Kratje R; Etcheverrigaray M
    Biotechnol Prog; 2011 Jul; 27(4):1018-28. PubMed ID: 21608141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Derivatives of erythropoietin that are tissue protective but not erythropoietic.
    Leist M; Ghezzi P; Grasso G; Bianchi R; Villa P; Fratelli M; Savino C; Bianchi M; Nielsen J; Gerwien J; Kallunki P; Larsen AK; Helboe L; Christensen S; Pedersen LO; Nielsen M; Torup L; Sager T; Sfacteria A; Erbayraktar S; Erbayraktar Z; Gokmen N; Yilmaz O; Cerami-Hand C; Xie QW; Coleman T; Cerami A; Brines M
    Science; 2004 Jul; 305(5681):239-42. PubMed ID: 15247477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sub-acute systemic erythropoietin administration reduces ischemic brain injury in an age-dependent manner.
    Thériault P; Le Béhot A; ElAli A; Rivest S
    Oncotarget; 2016 Jun; 7(24):35552-35561. PubMed ID: 27248662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of recombinant human erythropoietin on serum S100B protein and interleukin-6 levels after traumatic brain injury in the rat.
    Bian XX; Yuan XS; Qi CP
    Neurol Med Chir (Tokyo); 2010; 50(5):361-6. PubMed ID: 20505289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Erythropoietin-mediated preservation of the white matter in rat spinal cord injury.
    Vitellaro-Zuccarello L; Mazzetti S; Madaschi L; Bosisio P; Gorio A; De Biasi S
    Neuroscience; 2007 Feb; 144(3):865-77. PubMed ID: 17141961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential neuroprotective properties of endogenous and exogenous erythropoietin in a mouse model of traumatic brain injury.
    Shein NA; Grigoriadis N; Alexandrovich AG; Simeonidou C; Spandou E; Tsenter J; Yatsiv I; Horowitz M; Shohami E
    J Neurotrauma; 2008 Feb; 25(2):112-23. PubMed ID: 18260794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The nasal route as a potential pathway for delivery of erythropoietin in the treatment of acute ischemic stroke in humans.
    Garcia-Rodriguez JC; Sosa-Teste I
    ScientificWorldJournal; 2009 Sep; 9():970-81. PubMed ID: 19768354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.